Testagen
Also known as: Lys-Glu-Asp-Gly
Overview
A tetrapeptide bioregulator associated with testicular tissue in the Khavinson series.
Testagen is classified as a short peptide bioregulator. Its current development status is: preclinical / russian clinical use. The published evidence is thin, largely non-independent, or does not address the uses this compound is marketed for.
The Peptide Institute tracks Testagen because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Independent Testing
Independently tested companies that sell Testagen
Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.
- Companies
- 1
- Samples
- 1
- Updated
- Jul 4, 2026
- 1 Research Peptides Co. Exceptional Institute
Top Rated Testagen98% average purity across 1 sample
Purity & Testing 98 Transparency 84 Samples 1 90 View company
Research & Studies
Studies library-
Testagen: dose-ranging efficacy and safety findings
Reports findings relevant to the primary claims made for Testagen; sample size limits how far the result generalises.
-
Testagen: dose-ranging efficacy and safety findings
Characterises Testagen activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.
Independent Testing
Testing databaseLaboratory verification of Testagen products across the companies we index.
Community Discussions
ForumThe Peptide Institute Weekly
Research. Testing. Regulation. No hype.
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.
- New research, summarized in plain English
- Independent lab results as they publish
- Score and ranking movements
